2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Small Cell Lung Carcinoma
25
Neoplasms
7
Lung Neoplasms
5
Sarcoma
4
Ovarian Neoplasms
4
Breast Neoplasms
4
Sarcoma, Ewing
3
Neuroendocrine Tumors
3
Endometrial Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Advanced Solid Tumor
3
Neoplasm Metastasis
2
Mesothelioma
2
Desmoplastic Small Round Cell Tumor
2
Colorectal Neoplasms
2
Advanced Solid Tumors
2
Stomach Neoplasms
1
Solid Tumors
1
SCLC, Extensive Stage
1
Recurrence
1
Platinum-Resistant Lung Small Cell Carcinoma
1
Pancreatic Neoplasms
1
Neutropenia
1
Mesothelioma, Malignant
1
Major Advanced Solid Tumors Other Than Colorectal
1
Leukemia
1
Leiomyosarcoma
1
Glioblastoma
1
Gastrointestinal Malignancies
1
Gastro-enteropancreatic neuroendocrine tumor
1
Interventions
selinexor
1
sacituzumab govitecan
1
amrubicin
1
Topotecan
1
PM 01183
1
Drug Therapy
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
×
PM 01183
×
Clear all
NCT06801834
2026-05-20
EVOKE-SCLC-04
Gilead Sciences
Phase 3
Recruiting
695 enrolled